Demographics Sample Clauses
Demographics. Obtain demographic information including age, race, ethnicity, and sex.
Demographics. Core Data
Demographics. On an annual basis for the next two years, Respondent agrees to provide “tenant data” of all occupants at all their rental properties to the Commission. On or before May 15, 2014, and May 15, 2015, Respondent agrees to provide tenant data of all occupants as of April 1, 2014 and April 1, 2015. Tenant data for each rental unit shall include: (1) the address and apartment number of each rental unit;
Demographics. Prior to the District’s annual staffing meeting, Management and Association Officers will meet and consult to discuss the demographics for the coming year.
1. The Association will be provided with student demographics and anticipated number of classes at each grade level for each school not later than one (1) week prior to the District's annual staffing meeting. The information provided to Association officers shall be kept confidential until after teachers have been notified by their principal of a transfer.
2. Projected demographics for Special Day Classes will be shared with special education staff prior to the District’s annual staffing meeting.
Demographics. Orders and Requests;
Demographics. A. Age ≥ 12 years at the Screening Visit.
Demographics. Next to the events that might influence the need for the participant to get actively involved in their pension, the demographical information is important to take into account. Next to some general information such as gender and age, included was information on possible triggers in the past to get involved in their pension,
Demographics. K. Members shall be entitled to full rights of citizenship, and no religious or political activities (or lack of such activities) of any member, which do not interfere with or disrupt prescribed instructional programs or normal school operations and/or procedures, shall be grounds for any discipline or discrimination with respect to the professional employment of such member. The private and personal life of any member, which does not interfere with or disrupt prescribed instructional programs or normal school operations and/or procedures, is not within the appropriate concern or attention of the Board. Nothing in this Agreement is to be construed as in any way restricting the rights of the Board under the Michigan Teacher Tenure Act.
L. The provisions of this Agreement shall be applied without regard to race, creed, religion, color, national origin, age, sex, marital status, handicap, weight, or membership in or association with the activities of the Association.
M. The Board shall not distribute, in any form, personal information, i.e., name, address, phone, evaluations, etc. to public or private concern(s) except as required by national, state or local statutes or as necessary to operate the school district, unless permission is granted by the member.
N. The rights granted herein to the Association shall not be granted or extended to any competing labor organizations.
O. The Board shall provide in-district mail (including all consortium buildings) pick-up and delivery at least once every two weeks and shall endeavor to provide mail weekly.
Demographics. We believe that demographic trends in the U.S. population, the increase in under-insured individuals, the potential risk to governmental social safety net programs and the shifting of responsibility for retirement planning and financial security from employers and other institutions to individuals, highlight the need of individuals to plan for their long-term financial security and will create opportunities to generate significant demand for our products. By focusing our product development and marketing efforts to meeting the needs of certain targeted customer segments identified as part of our strategy, we will be able to focus on offering a smaller number of products that we believe are appropriately priced given current economic conditions. We believe this strategy will benefit our expense ratio thereby increasing our profitability.
Demographics. The mean age of the respondents was 45.1 years (range 30–64), 54.3% were female and 44.8% male. Most of the participating oncologists had breast cancer as area of interest (75.1%), other frequently mentioned areas of interest included colorectal, gynaecology and nephrology- urology, as depicted in Table 1. 2 Table 1. Demographic characteristics pter Demographic characteristics of participating oncologists (n=105) n (%) Cha Age (years) 218 Mean 45,1 years (range 30-64) Age 30-40 44 (41.9%) Age 40-50 26 (24.8%) Age 50-60 24 (22.9%) Age >60 10 (9.5%) Unknown 1 (1.0%) Sexual and fertility-related adverse effects of medicinal treatment for cancer Table 1. Demographic characteristics (continued) Male 47 (44.8%) Female 57 (54.3%) Unknown 1 (1.0%) 1-2 18 (17.1%) 3-5 26 (24.8%) 6-10 12 (11.4%) 11-15 17 (16.2%) >15 30 (28.6%) Unknown 2 (1.9%) Oncologist 66 (62.9%) Haematologist 9 (8.6%) Resident oncologist 18 (17.1%) Resident haematologist 12 (11.4%) University hospital 35 (33.3%) District general teaching hospital 25 (23.8%) District general hospital 39 (37.1%) Categorical cancer hospital 3 (2.9%) University hospital and district general hospital 2 (1.9%) Breast 79 (75.2%) Colorectal 70 (66.7%) Palliative care 52 (49.5%) Gynaecology 46 (43.8%) Nephrology and urology 48 (45.7%) Haematology 28 (26.7%) Lymphoma 27 (25.7%) Head and neck 14 (13.3%) Neuroendocrine 14 (13.3%) Skin 8 (7.6%) Sarcomas 8 (7.6%) Lung 3 (2.9%) Other 16 (15.2%) a Most oncologists reported multiple areas of expertise Table 2 shows which drugs that are used in cancer therapy, were mentioned to have a negative effect on fertility, ovulation, spermatogenesis and sexual function according to 100–105 medi- cal oncologists. Drugs of which 50% or more of oncologists marked ‘I don’t know’ whether these drugs negatively affect fertility, ovulation, spermatogenesis or sexual function, were chlormethine (n=73, 72.3%), aminogluthemide (n=65, 63.1%), interleukin-2 (n=62, 62.0%), cyproterone (n=55, 55.0%) and busulfan (n=51, 50.0%). Drugs that were most often believed to negatively affect fertility were cisplatin (n=81, 80.2%), epirubicin (n=78, 78.0%), cyclophosphamide (n=80, 77.7%), doxorubicin (n=76, 76.0%) and anthracycline (n=78, 75.0%). For sexual adverse effects, most mentioned drugs were tamoxifen (n=67, 65.7%), GnRH-agonists (n=64, 63.4%), autologous stem cell trans- plantation (n=59, 57.8%), cisplatin (n=58, 57.4%) and epirubicin (n=57, 57.0%). Drugs that were believed not to harm fertility were herc...